Serous-exudative retinal detachment differs from rhegmatogenous detachment in that it arises from an underlying systemic or ocular condition. When Vogt-Koyanagi-Harada syndrome is identified as the cause, management is directed at that underlying condition rather than surgical repair alone.
This protocol applies to patients with serous-exudative retinal detachment where Vogt-Koyanagi-Harada syndrome has been established as the causative diagnosis. Identifying and treating the cause is central to the management of this form of retinal detachment.
The structured protocol for this scenario involves systemic therapy targeting the underlying inflammatory process. The complete regimen — including agent selection, dosing, and sequencing — is available in the full protocol below.
DOI: 10.1016/S1060-135X(98)90029-X